ArticleVaccine2010

TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.

Jun Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.